14 Followers on Owler

Aurinia

focuses on the development and commercialization of novel drug products for the treatment of lupus nephritis... Read more
OverviewCompetitorsFundingNews & Insights

Aurinia

focuses on the development and commercialization of novel drug products for the treatment of lupus nephritis... Read more
Aurinia CEO: Peter Greenleaf

CEO

Peter Greenleaf

CEO Approval Rating

90/100

2013

PublicMerged with Isotechnika Pharma Inc.NASDAQAUPH

Pharmaceuticals & Biotechnology
Pharmaceuticals
2836 NAICS listing

Annual Revenue
$235.1M
Employees
130
Funding
$77M

News

Conference Presentation
Nov 14, 2024
Business Wire
Aurinia to Participate in Jefferies London Healthcare Conference
Layoffs
Nov 07, 2024
Endpoints News
Aurinia cuts nearly half of its workforce in second round of layoffs this year

Aurinia Competitors

1KLOTHO Therapeutics, Inc.
2KidneyCure
3Ardelyx
4Keryx
5Tricida
Unlock 2 + competitors

Trending Companies